Drugs / Aprepitant (MK-869) + Standard PO
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00781768 Comparator | Aug 2003 → Oct 2008 | — | Loyola University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aprepitant (MK-869) + Standard PO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00781768 ↗ |